A South African study | 23 Diciembre 2021

EURUSD trading plan:

A South African study suggests reduced risks of hospitalisation and severe disease in people infected with the Omicron coronavirus variant versus the Delta one. The study found that people diagnosed with Omicron in South Africa between Oct. 1 and Nov. 30 were 80% less likely to be admitted to hospital than those diagnosed with another variant in the same period. Among patients admitted in that period, those with Omicron had a similar chance of developing severe disease as those with other variants. Pfizer, one of the primary manufacturers of COVID-19 vaccines, said its antiviral COVID-19 pill was approved for at-home use. It targets people who have contracted the virus and is effective at reducing symptoms and hospitalizations, the company said. This is a positive signal for the European currency.

Investment idea: buy 1.1315 and take profit 1.1359.